Privigen 10% vial 200ML
Ended Awarded
- Contract number
- SPE2DB25FPRR3
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $43,378
Award facts
- Contract value 100% obligated
- $43,378.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $43.4 thousand to DMS Pharmaceutical Group Inc. on September 26, 2025, for the supply of Privigen 10% Vial 200ML, a pharmaceutical product. This delivery order operates under a larger indefinite delivery contract (IDC) valued at $500 million and valid through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical items supporting military healthcare facilities worldwide. The contract utilizes firm fixed-price pricing and carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on its merits as a woman-owned small business pharmaceutical wholesaler. The work will be performed in Park Ridge, Illinois, with an ultimate completion date of October 20, 2025.
DMS Pharmaceutical Group Inc., based in Park Ridge, Illinois, has been registered in SAM.gov since 2001 and serves as a critical supplier within the federal pharmaceutical supply chain. The company specializes in distributing branded and generic prescription drugs, biologics, over-the-counter medications, and medical consumables to Department of Defense healthcare facilities nationwide. This delivery order for Privigen, an immunoglobulin therapy product, represents one of numerous pharmaceutical procurements the company has successfully secured through the DLA's SPE2DB program, demonstrating its established capability to deliver specialized medical products to support military health operations.
Quick answers
Who was awarded contract SPE2DB25FPRR3?
SPE2DB25FPRR3 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FPRR3 worth?
The government has obligated $43,378 on SPE2DB25FPRR3.
Is contract SPE2DB25FPRR3 an order under another contract?
Yes. SPE2DB25FPRR3 is a delivery order under SPE2DB20D9127, an indefinite delivery contract.
Was contract SPE2DB25FPRR3 competed?
The extent of competition for SPE2DB25FPRR3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award